OxySure Therapeutics Inc Cash Flow Statement

OXYS $0.032 -0.0 -4.5%

25/07/18

Highly Speculative, Micro Cap,

Market Cap £n/a

Enterprise Value £n/a

Revenue £2.46m

Quality

Value

Momentum

StockRank™

To unlock OxySure Therapeutics Inc's cashflow statement please upgrade your membership.

	2009	2010	2011	2012	2013	2014
Period End:	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31
Period Length:	12M	12M	12M	12M	12M	12M
Currency:	USD	USD	USD	USD	USD	USD

Net Income/Starting Line

Depreciation/Depletion
Amortization
Non-Cash Items
Unusual Items
Other Non-Cash Items
Changes in Working Capital
Accounts Receivable
Inventories
Prepaid Expenses
Other Assets
Payable/Accrued
Other Liabilities
Cash from Operating Activities

Capital Expenditures
Purchase of Fixed Assets
Purchase/Acquisition of Intangibles
Other Investing Cash Flow Items, Total
Other Investing Cash Flow
Cash from Investing Activities

Financing Cash Flow Items
Other Financing Cash Flow
Issuance (Retirement) of Stock, Net
Issuance (Retirement) of Debt, Net
Cash from Financing Activities

Net Change in Cash
Starting Cash Balance
Ending Cash Balance

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.